Add to Calendar 5/5/2022 8:30:00 AM 5/5/2022 8:30:00 PM 2022 State of Possible Conference MassBio's annual State of Possible Conference celebrates how the life sciences make the impossible possible. We will tap today’s brightest minds for engaging conversations on the latest developments in our industry, key insights from the past year, and building a better future for patients around the world. This year's conference will explore the theme "The Massachusetts BioPharma Ecosystem in the Post- Covid Era."

Join MassBio and more than 500 attendees for a day of networking, keynotes, and panel discussions from some of the most inspiring voices in the industry, culminating in a reception celebrating the life sciences community. This is our most popular event so you will want to reserve your spot early.
Royal Sonesta Boston, 40 Edwin Land Blvd Cambridge MA 02142
VP, Head of Global Clinical Operations and interim Head of Analytics & Data Sciences, Biogen
Siân is currently VP, Head of Global Clinical Operations and interim Head of Analytics & Data Sciences at Biogen, where she leads large global teams accountable for the strategic planning, execution and analysis of clinical trials across all phases of development in the therapeutic areas of MS/Immunology, Neuromuscular Disorders, Neurodegenerative Disorders and Therapeutics Development (Neurovascular therapies, Psychiatry, and Genetic Neurodevelopmental Disorders). Siân and her team are driving numerous innovation projects to transform clinical trials and accelerate clinical development. Prior to Biogen, Siân spent 20+ years Pfizer, where she held leadership roles in Clinical Development & Operations, Medical Writing, Preclinical Safety (Toxicology and Safety Pharmacology), Safety Risk Management and Regulatory Strategy, managing projects throughout development stages from research to post-approval in multiple therapeutic areas (including Oncology, Neurology, Psychiatry, Pain, Rare Disease, Immunology, Internal Medicine and Vaccines). Sian has a PhD in Pharmacology from the University of Cambridge (1996) where she also held post-doctoral research and academic posts.

Brought to you by